A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma.
Constitutive activation of nuclear factor κB (NF-κB) is a hallmark of activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL). Mutations in the A20 gene activate NF-κB, but the prognostic value of A20 mutations in ABC-DLBLC is unclear.To investigate the prognostic value of A20 mutation in AB...
Main Authors: | Hong Cen, Xiaohong Tan, Baoping Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4696786?pdf=render |
Similar Items
-
Clinical and Prognostic Value of Molecular Markers of Diffuse Large B-Cell Lymphoma
by: SM Rastorguev, et al.
Published: (2018-12-01) -
Prognostic Markers in Diffuse Large B-cell Lymphoma : How Bad can it be
by: Hedström, Gustaf
Published: (2014) -
Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma
by: E. V. Kharchenko, et al.
Published: (2019-12-01) -
Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas
by: Alexandar Tzankov, et al.
Published: (2007-01-01) -
CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
by: Sun J, et al.
Published: (2021-04-01)